Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 14, 2017; 23(46): 8140-8151
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8140
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8140
Figure 5 SCD-1 knockdown alleviates the promoting effect of the miR-192-5p inhibitor on lipid accumulation.
The protein level of SCD-1 (A), Oil red O staining (B), and cellular TG levels (C) in Huh7 cells transfected with miR-192-5p inhibitor and SCD-1 siRNA followed by exposure to PA. The data are expressed as the mean ± SEM, bP < 0.01.
- Citation: Liu XL, Cao HX, Wang BC, Xin FZ, Zhang RN, Zhou D, Yang RX, Zhao ZH, Pan Q, Fan JG. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1. World J Gastroenterol 2017; 23(46): 8140-8151
- URL: https://www.wjgnet.com/1007-9327/full/v23/i46/8140.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i46.8140